Table 5.
Multi-Drug Resistance patterns (MDR) of Shigella species isolated from diarrheic pediatric population attended at selected Gondar town Healthcare institutions, Northwest Ethiopia, 2018, n = 272
| Species | Resistance Antibiotics | Number of organisms | group |
|---|---|---|---|
| Shigella (n = 5) | AMX | 1 | R1 |
| CAF | 1 | ||
| TE | |||
| AZM | 1 | ||
| AMC | |||
| Shigella (n = 6) | SXT, AMX | 1 | R2 |
| AMC, CAF | 1 | ||
| TE, AZM | 1 | ||
| AZM, NIT | 1 | ||
| TE, CAF | 1 | ||
| NOR, AMX | 1 | ||
| Shigella (n = 11) | AMX, TE, CAF, AZM | 1 | R3 |
| TE, AMC, AZM | 1 | ||
| TE, CAF, AZM | 1 | ||
| AMX, SXT, AMC, CAF | 1 | ||
| TE, AZM, SXT | 1 | ||
| AMX, SXT, CAF | 1 | ||
| AMX, SXT, AMC | 1 | ||
| TE, AZM, SXT | 1 | ||
| AMX, TE, AZM, SXT | 1 | ||
| TE, AMC, SXT | 1 | ||
| AMX, SXT, CAF, TE | 1 |
R1 Resistance for one drug, R2 Resistance for two drugs, ≥R3 Resistance for three or more drug